Skip to main content
BEIJING FOYOU PHARMA CO.,LTD logo

BEIJING FOYOU PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 601089 ISIN · CNE100005QF9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 451 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 601089

About BEIJING FOYOU PHARMA CO.,LTD

https://www.foyou.com.cn/

Beijing Foyou Pharma Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company specializes in the synthesis of active pharmaceutical ingredients (APIs) and the formulation of finished dosage forms across various therapeutic categories. Its core operations integrate advanced chemical synthesis technologies with rigorous quality control protocols to ensure compliance with international Good Manufacturing Practice (GMP) standards. Foyou Pharma provides a broad portfolio of generic medications and specialized pharmaceutical intermediates, serving healthcare providers and industrial partners. The organization emphasizes technical innovation and process optimization to enhance the efficacy and safety of its product offerings, maintaining a comprehensive infrastructure for large-scale manufacturing and global supply chain management.

Recent filings

Filing Released Lang Actions
北京福元医药股份有限公司关于氯吡格雷阿司匹林片获得药品注册证书的公告
Regulatory Filings Classification · 90% confidence The document is an official announcement by Beijing Fuyuan Pharmaceutical regarding the grant of a drug registration certificate by the National Medical Products Administration. It does not present financial results, governance materials, call transcripts, or any report itself but is a regulatory announcement of product approval. This falls under the general regulatory announcements category.
2026-05-21 Chinese
北京福元医药股份有限公司2025年年度股东会决议公告
Regulatory Filings
2026-05-07 Chinese
北京福元医药股份有限公司关于奥美沙坦酯口崩片获得药品注册证书的公告
Regulatory Filings
2026-05-07 Chinese
浙江天册律师事务所关于北京福元医药股份有限公司2025年年度股东会的法律意见书
Regulatory Filings
2026-05-07 Chinese
北京福元医药股份有限公司内部审计制度
Audit Report / Information Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) of Beijing Fuyuan Pharmaceutical Co., Ltd. It details the internal audit policies, responsibilities, organizational structure, audit procedures, and supervisory mechanisms within the company. It references internal control, audit committee, audit department, and compliance with laws and regulations. The document is a comprehensive internal audit policy document rather than a standalone audit report or financial statement. It does not contain financial data or audit results but rather the framework and rules governing internal audit activities. Therefore, it fits best under 'Audit Report / Information' (AR) as it relates to internal audit information and policies, not a full annual report or other categories.
2026-04-13 Chinese
北京福元医药股份有限公司2025年度审计报告
Regulatory Filings
2026-04-13 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.